Clinical Trials 2015,
TARGETED THERAPY CLL: FDA Approves Ibrutinib as Frontline…
Blood and Hematology,
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic…
Cancer Treatment Options And Management Inc,
Ibrutinib has become a major player in B-cell cancers and should be used as a single agent rather than standard chemotherapy.
Αιματολογος,
To Ibrutinib ειναι νεα βιολογικη θεραπεία για ασθενεις με χρονια λεμφογενη λευχαιμια. Ειναι βιολογικό φαρμακο απο το στομα με απο…